Related references
Note: Only part of the references are listed.Genetic cardiovascular risk factors and age-related macular degeneration
Paulina Haas et al.
ACTA OPHTHALMOLOGICA (2011)
Phosducin Regulates Transmission at the Photoreceptor-to-ON-Bipolar Cell Synapse
Rolf Herrmann et al.
JOURNAL OF NEUROSCIENCE (2010)
The pivotal role of the complement system in aging and age-related macular degeneration: Hypothesis re-visited
Don H. Anderson et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2010)
Can novel therapeutics halt the amyloid cascade?
Niels D. Prins et al.
ALZHEIMERS RESEARCH & THERAPY (2010)
Soluble and Mature Amyloid Fibrils in Drusen Deposits
J. Mario Isas et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2010)
Microarray Analysis Identifies Changes in Inflammatory Gene Expression in Response to Amyloid-β Stimulation of Cultured Human Retinal Pigment Epithelial Cells
Khaliq H. Kurji et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2010)
Amyloid-β(1-42) alters structure and function of retinal pigmented epithelial cells
Julien Bruban et al.
AGING CELL (2009)
Unraveling a Multifactorial Late-Onset Disease: From Genetic Susceptibility to Disease Mechanisms for Age-Related Macular Degeneration
Anand Swaroop et al.
ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS (2009)
Drusen are associated with local and distant disruptions to human retinal pigment epithelium cells
Heba Al-Hussaini et al.
EXPERIMENTAL EYE RESEARCH (2009)
Age-Related Macular Degeneration and Functional Promoter and Coding Variants of the Apolipoprotein E Gene
Lars G. Fritsche et al.
HUMAN MUTATION (2009)
Amyloid-β Up-Regulates Complement Factor B in Retinal Pigment Epithelial Cells Through Cytokines Released From Recruited Macrophages/Microglia: Another Mechanism of Complement Activation in Age-Related Macular Degeneration
Jiying Wang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
Medical progress: Age-related macular degeneration
Rama D. Jager et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Targeting age-related macular degeneration with Alzheimer's disease based immunotherapies:: Anti-amyloid-β antibody attenuates pathologies in an age-related macular degeneration mouse model
Jin-Dong Ding et al.
VISION RESEARCH (2008)
Experimental investigation of antibody-mediated clearance mechanisms of amyloid-β in CNS of Tg-SwDI transgenic mice
Vitaly Vasilevko et al.
JOURNAL OF NEUROSCIENCE (2007)
A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration
Atsuhiro Kanda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Cone- and rod-mediated dark adaptation impairment in age-related maculopathy
Cynthia Owsley et al.
OPHTHALMOLOGY (2007)
Complement C3 variant and the risk of age-related macular degeneration
John R. W. Yates et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration
Zhenglin Yang et al.
SCIENCE (2006)
HTRA1 promoter polymorphism in wet age-related macular degeneration
Andrew DeWan et al.
SCIENCE (2006)
Deglycosylated anti-amyloid-β antibodies eliminate cognitive deficits and reduce parenchymal amyloid with minimal vascular consequences in aged amyloid precursor protein transgenic mice
Donna M. Wilcock et al.
JOURNAL OF NEUROSCIENCE (2006)
Intracranial administration of deglycosylated C-terminal-specific anti-Aβ antibody efficiently clears amyloid plaques without activating microglia in amyloid-depositing transgenic mice
Niki C. Carty et al.
JOURNAL OF NEUROINFLAMMATION (2006)
Apolipoprotein (APOE) gene is associated with progression of age-related macular degeneration (AMD)
PN Baird et al.
HUMAN MUTATION (2006)
Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration
B Gold et al.
NATURE GENETICS (2006)
Drusen deposits associated with aging and age-related macular degeneration contain nonfibrillar amyloid oligomers
V Luibl et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Age-related macular degeneration - emerging pathogenetic and therapeutic concepts
Karen M. Gehrs et al.
ANNALS OF MEDICINE (2006)
Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk
A Rivera et al.
HUMAN MOLECULAR GENETICS (2005)
The potential role of amyloid β in the pathogenesis of age-related macular degeneration
T Yoshida et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Apolipoprotein E allele-dependent pathogenesis: A model for age-related retinal degeneration
G Malek et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Toll-like receptor 4 variant D299G is associated with susceptibility to age-related macular degeneration
S Zareparsi et al.
HUMAN MOLECULAR GENETICS (2005)
A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration
GS Hageman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Complement factor H polymorphism in age-related macular degeneration
RJ Klein et al.
SCIENCE (2005)
Complement factor H polymorphism and age-related macular degeneration
AO Edwards et al.
SCIENCE (2005)
Complement factor H variant increases the risk of age-related macular degeneration
JL Haines et al.
SCIENCE (2005)
Cone- and rod-mediated multifocal electroretinogram in early age-related maculopathy
B Feigl et al.
EYE (2005)
Novel monoclonal antibodies against mouse C3 interfering with complement activation:: description of fine specificity and applications to various immunoassays
D Mastellos et al.
MOLECULAR IMMUNOLOGY (2004)
Characterization of β amyloid assemblies in drusen:: the deposits associated with aging and age-related macular degeneration
DH Anderson et al.
EXPERIMENTAL EYE RESEARCH (2004)
Pegaptanib for neovascular age-related macular degeneration
ES Gragoudas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Missense variations in the fibulin 5 gene and age-related macular degeneration
EM Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Passive amyloid immunotherapy clears amyloid and transiently activates microglia in a transgenic mouse model of amyloid deposition
DM Wilcock et al.
JOURNAL OF NEUROSCIENCE (2004)
Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease
I Ferrer et al.
BRAIN PATHOLOGY (2004)
Association of apolipoprotein E alleles with susceptibility to age-related macular degeneration in a large cohort from a single center
S Zareparsi et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2004)
Differential binding to human FcγRIIa and FcγRIIb receptors by human IgG wildtype and mutant antibodies
KL Armour et al.
MOLECULAR IMMUNOLOGY (2003)
Evidence for peripheral clearance of cerebral Aβ protein following chronic, active Aβ immunization in PSAPP mice
CA Lemere et al.
NEUROBIOLOGY OF DISEASE (2003)
New treatments in age-related macular degeneration
CY Hooper et al.
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2003)
Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide:: a case report
JAR Nicoll et al.
NATURE MEDICINE (2003)
Progression of age-related macular degeneration - Association with dietary fat, transunsaturated fat, nuts, and fish intake
JM Seddon et al.
ARCHIVES OF OPHTHALMOLOGY (2003)
Pubertal changes in biochemical markers of growth
G Federico et al.
HORMONE RESEARCH (2003)
Incidence of age-related cataract over a 10-year interval - The Beaver Dam Eye Study
BEK Klein et al.
OPHTHALMOLOGY (2002)
The Alzheimer's Aβ-peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration
LV Johnson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
The contrasting IgG-binding interactions of human and herpes simplex virus Fc receptors
KL Armour et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2002)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Clusterin is present in drusen in age-related macular degeneration
H Sakaguchi et al.
EXPERIMENTAL EYE RESEARCH (2002)
Brain to plasma amyloid-β efflux:: a measure of brain amyloid burden in a mouse model of Alzheimer's disease
RB DeMattos et al.
SCIENCE (2002)
An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration
GS Hageman et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2001)
Dietary fat and risk for advanced age-related macular degeneration
JM Seddon et al.
ARCHIVES OF OPHTHALMOLOGY (2001)
Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease
RB DeMattos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Local cellular sources of apolipoprotein E in the human retina and retinal pigmented epithelium: Implications for the process of drusen formation
DH Anderson et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2001)
Immunological and aetiological aspects of macular degeneration
PL Penfold et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2001)
Further evidence for an association of ABCR alleles with age-related macular degeneration
R Allikmets
AMERICAN JOURNAL OF HUMAN GENETICS (2000)
A potential role for immune complex pathogenesis in drusen formation
LV Johnson et al.
EXPERIMENTAL EYE RESEARCH (2000)
Share Paper
